glp-1 gastrointestinal obstruction class action in michigan semaglutide gastric intestinal lawsuit diarrhea Ozempic Lawsuit [May 2026 Update] Ozempic Lawsuit glp-1 digestive blockage law firm

Whether UHC covers Wegovy or Zepbound depends on whether your specific employer plan opted into the weight-loss drug rider

Typically, all samples are shipped the same day or within 24 hours to a DoD-certified laboratory

Novo Nordisk Details SOUL Trial Behind Rybelsus MACE Approval Novo Nordisk Canada president Vince Lamanna detailed the SOUL trial of 9,650 patients behind Health Canada's MACE indication expansion for Rybelsus tablets

Those unwilling or unable to commit to regular follow-up appointments and monitoring

How often do you inject peptide therapy

After adjusting for potentially influential factors including age, sex, ethnicity, pre-existing conditions, other medication use, and body mass index, use of GLP-1 receptor agonists was associated with a 37% higher risk of alopecia than use of SGLT-2 inhibitors (6.91 v 5.04 per 1,000 person years) and a 68% higher risk than use of DPP-4 inhibitors (6.53 v 3.89 per 1,000 person years)